AbbVie Corporation
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
AbbVie Corporation engages the British Columbia Government to advocate for policies that support timely access to AbbVie’s innovative medicines for appropriate patients. More specifically, we engage with government to: Advocate of the value of innovative pharmaceuticals in improving patient outcomes and overall savings to the healthcare system, as well as advancing health security and economic growth.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Advanced Education, Children and Families, Colleges & Universities, Economic Development and Trade, Finances and Budgets, Health, Indigenous Relations and Reconciliation, Mental Health and Addictions, Science and Technology, Senior Citizens
|
|
Advocate for pharmaceutical pricing and reimbursement policies that reflect the value of new medicines to patients and the health care system.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
|
Help support health system improvements and healthcare outcomes.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health, Mental Health and Addictions
|
|
Identify partnership opportunities with the Government of British Columbia, Regional Health Authorities, BC Cancer Agency, and Universities in clinical research on new and existing treatments and therapies, and the generation of real-world evidence.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Advanced Education, Colleges & Universities, Health, Mental Health and Addictions
|